CPX-351 improves outcomes for refractory AML

Dr Jeffrey Lancet - H. Lee Moffitt Cancer Center, Tampa, USA
CPX-351 improves outcomes for refractory AML ( Dr Jeffrey Lancet - H. Lee Moffitt Cancer Center, Tampa, USA )
6 Jun 2016

ASCO 2016: Plenary Session Review

Dr Julie Vose - President of ASCO
ASCO 2016: Plenary Session Review ( Dr Julie Vose - President of ASCO )
5 Jun 2016

Novel daratumumab-based regimen slows multiple myeloma progression

Prof Antonio Palumbo - University of Torina, Turin, Italy
Novel daratumumab-based regimen slows multiple myeloma progression ( Prof Antonio Palumbo - University of Torina, Turin, Italy )
5 Jun 2016

Liquid biopsy may help guide treatment decisions for advanced solid tumours

Prof Philip Mack - University of California Davis, Davis, USA
Liquid biopsy may help guide treatment decisions for advanced solid tumours ( Prof Philip Mack - University of California Davis, Davis, USA )
4 Jun 2016

Liquid biopsy may help guide treatment decisions for advanced solid tumours

Prof Philip Mack - University of California Davis, Davis, USA
Liquid biopsy may help guide treatment decisions for advanced solid tumours ( Prof Philip Mack - University of California Davis, Davis, USA )
4 Jun 2016

ASCO 2016: Expert discussion on the latest on multiple myeloma

Dr Sagar Lonial and Dr Paul Richardson
ASCO 2016: Expert discussion on the latest on multiple myeloma ( Dr Sagar Lonial and Dr Paul Richardson )
3 Jun 2016

Hodgkins - update on treatment strategies in children and adolescents

Prof Christine Mauz-Körholz - University of Giessen, Giessen, Germany
Hodgkins - update on treatment strategies in children and adolescents ( Prof Christine Mauz-Körholz - University of Giessen, Giessen, Germany )
6 May 2016

Use of novel agents in childhood ALL

Prof Lia Gore - Children's Hospital Colarado, Aurora, USA
Use of novel agents in childhood ALL ( Prof Lia Gore - Children's Hospital Colarado, Aurora, USA )
6 May 2016

Radiotherapy in Hogkin lymphoma: reducing risk in later life

Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Radiotherapy in Hogkin lymphoma: reducing risk in later life ( Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK )
6 May 2016

Relapsed Hodgkin lymphoma in PET positive patients

Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Relapsed Hodgkin lymphoma in PET positive patients ( Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK )
6 May 2016

Treatment of relapsed myeloma with novel targeted and immune therapies

Dr Kenneth Anderson - Dana–Farber Cancer Institute, Boston, USA
Treatment of relapsed myeloma with novel targeted and immune therapies ( Dr Kenneth Anderson - Dana–Farber Cancer Institute, Boston, USA )
5 May 2016

Understanding personalised medicine - the e-learning course

Prof Gordon McVie
Understanding personalised medicine - the e-learning course ( Prof Gordon McVie )
4 May 2016